Sleep Respiratory Disorders and Clinical Profile in Patients with Type 2 Diabetes Mellitus

Abstract

Introduction Sleep respiratory disorders (SRDs) are often found in patients with type 2 diabetes mellitus (T2DM). Objective The aim was to establish the prevalence of risk to develop an SRD using the Clinical Berlin Questionnaire (CBQ) and Epworth Sleepiness Scale (ESS) in patients with T2DM and verifying the correlation of anthropometric measurements and life quality (LQ) with ESS. Methods A descriptive and analytical study of a case series evaluating 208 patients with T2DM, submitted to clinical and biochemical evaluation and implementation of CBQ, ESS, and WHOQOL-bref to evaluate LQ. Results Mean age was 60.8 ± 8.8 years, and 65.4% were women. Most diabetics were overweight (36.1%), and 29.8% were class I obese. One-third had positive risk signals for a SRD, with 87.0 and 34.1% having high risk in CBQ and sleep disorders in ESS, respectively. There was a significant difference in the general LQ between the low- and high-risk groups in the CBQ. Conclusion In this scenario, it is noteworthy that the active search for sleep disorders must start from simple methods, such as application of protocols.

Predictors of Sleep Quality Among Type 2 Diabetes Mellitus Patients

“…Various factors have contributed to DM-related sleep problems. Those contributing factors include obesity and overweight, respiratory issues linked to sleep such as obstructive sleep apnea, poor bladder and bowel control caused by autonomic neuropathy, pain, and discomfort caused by diabetic neuropathy, nocturnal polyuria due to hyperglycemia (Arora et al, 2016;Fontela & Berlezi, 2015). Other conditions, such as stress also strongly associated with sleep problems (Merrill, 2022).…”

Avaliação da sonolência do estudante de Medicina no Brasil e sua influência na qualidade de vida e ambiente de ensino

“…Poucos estudos compararam a associação do WHOQOL-BREF com a escala de Epworth, e esses estudos são de populações específicas, como pacientes idosos, com dor crônica, insuficiência cardíaca congestiva, fibrose cística, refluxo gastroesofágico, apneia do sono ou diabetes (Asghari et al, 2013;Brandão et al, 2018;Diaferia et al, 2013;Fontela et al, 2015;Forte et al, 2015;Kim et al, 2013;Liu et al, 2011;Tasbakan et al, 2018;Uchmanowicz et al, 2018;Yosunkaya et al, 2016). (Abraham et al, 2008;Aghamolaei and Fazel, 2010;Bouhaimed et al, 2009;Jiffry et al, 2005;Pai et al, 2014;Vieira et al, 2003).…”